These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 14068996)

  • 1. [ON USE OF THE BLOCKING AGENT ALDOSTERONE].
    KUKES VG
    Klin Med (Mosk); 1963 Jun; 41():65-9. PubMed ID: 14068996
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
    Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
    J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: On the role of diuretic-and spironolactone-induced hyperaldosteronism on electrolyte excretion in man.
    Erbler H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R19. PubMed ID: 4276539
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in aldosterone receptors in congestive heart disease. Report of a case].
    Sánchez G; Posadas C; Boyer JL; Guzmán J; Serrano P
    Arch Inst Cardiol Mex; 1980; 50(4):461-9. PubMed ID: 7469590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutically induced aldosteronism in hydropic cardiac insufficiency].
    Kaufmann W
    Arzneimittelforschung; 1969 May; 19(5):802-3. PubMed ID: 5819794
    [No Abstract]   [Full Text] [Related]  

  • 7. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of spironolactone on the excretion of sodium and potassium in the saliva in secondary hyperaldosteronism].
    Vancura P
    Cas Lek Cesk; 1969 Mar; 108(10):308-9. PubMed ID: 5775579
    [No Abstract]   [Full Text] [Related]  

  • 9. [ENDOCRINOLOGICAL ASPECTS OF THE POTASSIUM DEPLETION SYNDROME].
    KUECHEL O; HORKY K; JIRANKOVA J; KAPITOLA J
    Sb Lek; 1963 Jun; 65():169-78. PubMed ID: 14072172
    [No Abstract]   [Full Text] [Related]  

  • 10. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aldosterone and magnesium].
    Matsuoka H
    Clin Calcium; 2005 Feb; 15(2):187-91. PubMed ID: 15692156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretics and bone loss in rats with aldosteronism.
    Law PH; Sun Y; Bhattacharya SK; Chhokar VS; Weber KT
    J Am Coll Cardiol; 2005 Jul; 46(1):142-6. PubMed ID: 15992648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hyperaldosteronism syndrome in edema caused by decompensated respiratory insufficiency and its treatment by spirolactones].
    BALMES A; VEDEL A; DAUVERCHAIN J; DUMAS A
    Poumon Coeur; 1962; 18():747-54. PubMed ID: 13966193
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diuretic therapy in heart failure].
    Splendiani G; Condò S
    G Ital Nefrol; 2006; 23 Suppl 34():S74-6. PubMed ID: 16634001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SECONDARY ALDOSTERONISM AND REFRACTORY OEDEMATOUS STATES.
    STEINBECK AW
    Bull Postgrad Comm Med Univ Syd; 1963 Nov; 19():208-13. PubMed ID: 14082846
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tissular aldactone saliuretic inhibitor of aldosterone. Its significance in the treatment of edemas associated with secondary hyperaldosteronism].
    MURISASCO A; REYNAUD M; BOUISSON M
    Sem Hop; 1961 Dec; 37():3421-5. PubMed ID: 14477376
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperaldosteronism.
    Nadar S; Lip GY; Beevers DG
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):439-52. PubMed ID: 14503982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total exchangeable potassium, sodium and chloride in patients with severe valvular heart disease during preparation for cardiac surgery.
    Olesen KH; Valentin N
    Scand J Thorac Cardiovasc Surg; 1973; 7(1):37-44. PubMed ID: 4121056
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement.
    Ruel M; Kapila V; Price J; Kulik A; Burwash IG; Mesana TG
    Circulation; 2006 Jul; 114(1 Suppl):I541-6. PubMed ID: 16820634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.